Patterns of use of oral antivirals for COVID-19 in people 70 years and over in Victoria, Australia: a linked data study. [PDF]
Edwards LJ +6 more
europepmc +1 more source
Viral kinetics in adults with Covid-19 treated with nirmatrelvir-ritonavir or molnupiravir: a population-based, observational cohort study. [PDF]
Prager M +16 more
europepmc +1 more source
Human liver-derived organoids recapitulate Oropouche virus infection and manifestation, enabling antiviral drug discovery. [PDF]
Li J +29 more
europepmc +1 more source
Combination Therapeutic Effect of Antibacterial and Antiviral Agents on Feline Chronic Gingivostomatitis Nonbounded to Prior Tooth Extraction Confirmed by Physical Signs and Clinical Biomarkers. [PDF]
Katayama M, Uemura Y.
europepmc +1 more source
Medication errors and associated serious outcomes in COVID-19 antivirals: a real-world study based on FDA Adverse Event Reporting System database. [PDF]
Xiong X, Chen Z, Yan B.
europepmc +1 more source
Impact of Early COVID-19 Antiviral Therapy on the Incidence of Uveitis: A Retrospective Cohort Study Using the TriNetX Database. [PDF]
Kuo HT +14 more
europepmc +1 more source
Designing Novel Compound Candidates Against SARS-CoV-2 Using Generative Deep Neural Networks and Cheminformatics. [PDF]
Li SY, Hung CM, Hung HY, Lai CW, Lee MC.
europepmc +1 more source
Antiviral Activity of Essential Oil from <i>Populus balsamifera</i> L. Buds and Its Major Compounds Against Betacoronavirus HCoV-OC43 Using a Sensitive Cytoprotection Assay. [PDF]
Girard L +5 more
europepmc +1 more source
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in reducing the risk of short-term and long-term cardiovascular complications of COVID-19: a target trial emulation study. [PDF]
Guo Z +16 more
europepmc +1 more source
Is it "time to eliminate" time to elimination of symptoms as a primary trial endpoint for respiratory virus targeting drugs? [PDF]
Schiffer JT +4 more
europepmc +1 more source

